Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women.

BACKGROUND Dietary fat has been reported to influence insulin sensitivity. OBJECTIVE The objective of the study was to determine how identical weight loss (target: loss of 8% of body weight over 3-6 mo) in women taking orlistat or placebo combined with a hypocaloric diet influences body composition and insulin sensitivity. DESIGN Forty-seven obese women [body mass index (in kg/m(2)): 32.1 +/- 0.4] were randomly assigned to receive either orlistat (120 mg 3 times daily; n = 23) or placebo (n = 24) with a hypocaloric diet. Whole-body insulin sensitivity (insulin clamp technique), serum fatty acids, and body composition (magnetic resonance imaging) were measured before and after weight loss. RESULTS The groups did not differ significantly at baseline with respect to age, body weight, intraabdominal and subcutaneous fat volumes, or insulin sensitivity. Weight loss did not differ significantly between the orlistat (7.3 +/- 0.2 kg, or 8.3 +/- 0.1%) and placebo (7.4 +/- 0.2 kg, or 8.2 +/- 0.1%) groups. Insulin sensitivity improved significantly (P < 0.001) and similarly after weight loss in the orlistat (from 4.0 +/- 0.3 to 5.1 +/- 0.3 mg x kg fat-free mass(-1) x min(-1)) and placebo (from 4.4 +/- 0.4 to 5.4 +/- 0.4 mg x kg fat-free mass(-1) x min(-1)) groups. Intraabdominal fat and subcutaneous fat decreased significantly in both groups, but the ratio of the 2 decreased significantly only in the orlistat group. The proportion of dihomo-gamma-linolenic acid (20:3n-6) in serum phospholipids was inversely related to insulin sensitivity both before (r = -0.48, P < 0.001) and after (r = -0.46, P < 0.001) weight loss, but it did not change significantly in either group. CONCLUSIONS Weight loss rather than inhibition of fat absorption enhances insulin sensitivity. A decrease in fat absorption by orlistat appears to favorably influence the ratio between intraabdominal and subcutaneous fat, which suggests that exogenous fat or its composition influences fat distribution.

[1]  D. Finegood,et al.  A Comparison of the Effects of n-3 Fatty Acids From Linseed Oil and Fish Oil in Well-Controlled Type II Diabetes , 1996, Diabetes Care.

[2]  G. Hunter,et al.  Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and white women. , 2002, The American journal of clinical nutrition.

[3]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[4]  S. Clarke.  Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance , 2000, British Journal of Nutrition.

[5]  Catherine Kim,et al.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.

[6]  S. Klein,et al.  Orlistat inhibits dietary cholesterol absorption. , 2001, Obesity research.

[7]  B. Desbuquois,et al.  Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. , 1971, The Journal of clinical endocrinology and metabolism.

[8]  A. Tremblay,et al.  Reduction of visceral adipose tissue during weight loss , 2002, European Journal of Clinical Nutrition.

[9]  K. Frayn.  Visceral fat and insulin resistance — causative or correlative? , 2000, British Journal of Nutrition.

[10]  L. Berglund,et al.  Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomised controlled trial , 2001, International Journal of Obesity.

[11]  P. Kris-Etherton,et al.  Individual fatty acid effects on plasma lipids and lipoproteins: human studies. , 1997, The American journal of clinical nutrition.

[12]  G. Everson,et al.  Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss , 2001, American Journal of Gastroenterology.

[13]  R R Wing,et al.  Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. , 1999, Diabetes.

[14]  F. Schick,et al.  Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. , 2001, Diabetes.

[15]  E. Kraegen,et al.  Influence of Dietary Fat Composition on Development of Insulin Resistance in Rats: Relationship to Muscle Triglyceride and ω-3 Fatty Acids in Muscle Phospholipid , 1991, Diabetes.

[16]  A. Häkkinen,et al.  Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. , 2000, Diabetes.

[17]  J. Zhi,et al.  Retrospective population‐based analysis of the dose‐response (fecal fat excretion) relationship of orlistat in normal and obese volunteers , 1994, Clinical pharmacology and therapeutics.

[18]  J. Aikens,et al.  A microfluorometric method for the determination of free fatty acids in plasma. , 1983, Journal of lipid research.

[19]  R. Schwartz,et al.  Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. , 2000, The Journal of clinical endocrinology and metabolism.

[20]  A. Häkkinen,et al.  Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. , 2001, Diabetes.

[21]  H C Lukaski,et al.  Assessment of fat-free mass using bioelectrical impedance measurements of the human body. , 1985, The American journal of clinical nutrition.

[22]  D. Doddrell,et al.  Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected]. , 2002, Obesity research.

[23]  A. Häkkinen,et al.  Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy , 2002, AIDS.

[24]  H. Lithell,et al.  Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men , 1994, Diabetologia.

[25]  Roberto Vettor,et al.  Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. , 2002, Diabetes.

[26]  S. Rössner,et al.  Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. , 2000, Obesity research.

[27]  A. Häkkinen,et al.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.

[28]  B. M. Rasmussen,et al.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.

[29]  D. Chisholm,et al.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.

[30]  N. Tajima,et al.  Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy--a randomized controlled trial. , 2001, Metabolism: clinical and experimental.

[31]  S. Lemieux,et al.  Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. , 2001, Diabetes.

[32]  S. Lillioja,et al.  Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action , 1997, Diabetes.

[33]  R. Kreis,et al.  Postexercise fat intake repletes intramyocellular lipids but no faster in trained than in sedentary subjects. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[34]  B. Vessby,et al.  Fatty acid composition of skeletal muscle reflects dietary fat composition in humans. , 2002, The American journal of clinical nutrition.

[35]  G. Hunter,et al.  Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. , 2001, The American journal of clinical nutrition.

[36]  A. Häkkinen,et al.  Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. , 2002, Obesity research.

[37]  F. Schick,et al.  Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. , 1999, Diabetes.

[38]  L. DiPietro,et al.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study , 1999, Diabetologia.

[39]  C. Bouchard,et al.  Genetic influences on the response of body fat and fat distribution to positive and negative energy balances in human identical twins. , 1997, The Journal of nutrition.

[40]  K. Fujioka,et al.  Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. , 1999, The American journal of clinical nutrition.

[41]  M. Mancini,et al.  Long-Term Effects of Fish Oil on Insulin Resistance and Plasma Lipoproteins in NIDDM Patients With Hypertriglyceridemia , 1996, Diabetes Care.

[42]  A. Rissanen,et al.  Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. , 2000, Archives of internal medicine.

[43]  J. Oppert,et al.  Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid Profile in Type 2 Diabetic Men: Results of a controlled study , 1998, Diabetes Care.

[44]  M. Ohrvall,et al.  The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up. , 1996, Atherosclerosis.

[45]  A. Shuldiner,et al.  Impaired capacity to lose visceral adipose tissue during weight reduction in obese postmenopausal women with the Trp64Arg beta3-adrenoceptor gene variant. , 2000, Diabetes.

[46]  A. Rissanen,et al.  The effect of orlistat on the fatty acid composition of serum lipid fractions in obese subjects , 1999, Clinical pharmacology and therapeutics.

[47]  Alain Golay,et al.  Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients , 1998, The Lancet.

[48]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[49]  R. Ross,et al.  Effects of an energy-restrictive diet with or without exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese women. , 2002, Diabetes care.

[50]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[51]  A. Ferro-Luzzi,et al.  Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. , 1987, The American journal of clinical nutrition.

[52]  D. A. Hall,et al.  A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. , 1965, Clinical chemistry.

[53]  W. Stoffel,et al.  Analysis of Long-Chain Fatty Acids by Gas-Liquid Chromatography , 1959 .

[54]  L. Lönn,et al.  Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. , 1997, The Journal of clinical endocrinology and metabolism.

[55]  F. Schick,et al.  Orlistat (Xenical®) improves insulin sensitivity (IS) in obese intentionally weight maintaining subjects , 2000 .

[56]  E. Muls,et al.  The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study , 2001, International Journal of Obesity.

[57]  U. Stenman,et al.  Rapid chromatographic quantitation of glycosylated haemoglobins. , 1984, Journal of chromatography.

[58]  Scott Owens,et al.  Effects of exercise intensity on cardiovascular fitness, total body composition, and visceral adiposity of obese adolescents. , 2002, The American journal of clinical nutrition.

[59]  N. Tajima,et al.  Effect of troglitazone on body fat distribution in type 2 diabetic patients. , 1999, Diabetes care.

[60]  S. Heymsfield,et al.  Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. , 1999, JAMA.

[61]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[62]  A. Rivellese,et al.  Type of Dietary Fat and Insulin Resistance , 2002, Annals of the New York Academy of Sciences.